Pharmaceutical Forecasting
We offer analytics and forecasting services to gain a deeper insight into the market potential of new products and factors that might impact the commercial trajectory of drug products.
Our specialists use advanced market sizing methodologies that can help to predict market share and future sales. The insights gained from pharmaceutical forecasting will enable businesses to support decision making, drive growth, highlight potential risks and increase innovation through the drug development and launch lifecycle.
Our Forecasting Methodology
We use an evidence-based approach and proven forecasting methods to create accurate forecasts, backed by expert data, including epidemiological modelling that draws on disease prevalence and incident data, as well as prescription and claims data, and market sizing models.
Read more about our methodology
Working with epidemiological data enables us to understand the drivers of disease, helping us better predict market dynamics and market size. Unlike a more straightforward sales forecasting approach, our available data allows us to go deeper and gives us a stronger position to enable scenario planning. We assess multiple potential scenarios using a sophisticated model, which allows us to account for uncertainties, provide risk-adjusted estimates across markets, and provide a structured view of the resources needed for operations.
We take insights from doctors, patients and payers, coupled with quantitative modelling techniques to create more accurate forecasts that can account for treatment patterns, regulatory approvals and clinical outcomes. This strengthens our overall forecasting capabilities, improves accuracy, and allows us to evaluate not just the clinical potential of upcoming pharmaceutical products, but also the long-term commercial potential.
Forecasting for Market Access and Product Strategy
Market access in the pharmaceutical industry refers to the negotiations, policies and strategies that allow for products to be readily available in a specific market, ensuring that patients are able to obtain medication whilst securing favourable reimbursement terms from healthcare systems.
Read more
Factoring the impact of market access into pharmaceutical forecasts helps to support decision-making beyond sales projections. Forecasts also inform pricing, determine affordability of drug products, how many patients will access the products and also demonstrate the value of treatments and therapies to payers. Using forecasts for market access can also demonstrate how treatments align with unmet needs, and what the potential impact on healthcare budgets could look like.
Our analytical approach to forecasting helps to inform decisions during the product development phase by showing where resources should be allocated, as well as planning drug launch potential, adoption rates and growth strategies. Ultimately, this contributes to solutions that achieve both patient impact and commercial success.
Therapeutic Area Expertise
We have a broad range of experience across multiple therapeutic areas, including oncology, immunology, neurology and rare diseases. The therapeutic area involved will alter the forecasting requirements – for example, a forecast for a rare disease will have a smaller patient population and highly specialised treatment pathways, whilst an oncology forecast will need to account for rapidly changing pipelines.
Our team has a wealth of scientific, clinical and commercial knowledge that allows us to have a deep understanding of treatment pathways, patient journeys and clinical development, which means we can build specialised patient based models that accurately reflect the dynamics of the specific therapeutic area.
Use Cases in Pharma and Life Sciences
Pharmaceutical forecasting is an extremely versatile and valuable tool, as it can be applied throughout the product life cycle. In the early stages it can help to support investment decisions by sizing potential markets for pipeline assets, and evaluate licensing and acquisition opportunities.
Forecasting for pharma companies and life sciences companies can also guide launch strategy, as it can give insight into adoption curves, peak sales and peak share, as well as enabling scenario planning to anticipate potential competitor launches, new data from trials, or changes in treatment guidelines and healthcare systems. Ultimately, forecasts equip companies with the knowledge they need to identify opportunities for growth and make more informed decisions.
FAQ
A frequently asked question surrounding your service
A frequently asked question surrounding your service
A frequently asked question surrounding your service
A frequently asked question surrounding your service
A frequently asked question surrounding your service
A frequently asked question surrounding your service
A frequently asked question surrounding your service
A frequently asked question surrounding your service
Get Custom Forecasting Support
Rosenblatt Life Science Consultants provides tailored forecasting services to pharmaceutical and life science businesses, accounting for the unique dynamics of every single product, indication and market. We work with clients across all stages of the lifecycle, whether they have assets still in early development or require assistance for in-market products.
Forecasting can be complicated and resource intensive, so we aim to streamline the process. We combine commercial insights, therapeutic expertise, and cutting-edge forecasting software, we deliver forecasts that allow our clients to better manage risk, find opportunities and realise the full potential of their pharmaceutical products.
